Dallas Mavericks guard/forward Naji Marshall (foot) has been ruled out for the remainder of Thursday's game against the Lakers. Marshall produced 19 points on 8-of-13 shooting with two rebounds, four assists, and two steals in 29 minutes before exiting. He was already dealing with the foot issue entering the game, which raises concern about a potential aggravation. If he misses time, P.J. Washington should absorb more frontcourt responsibility, while Caleb Martin (ankle) could see an expanded role if cleared.

Dallas Mavericks center Daniel Gafford (ankle) will not return to Thursday's game against the Lakers. He finished with two points, six rebounds, and one block in 28 minutes before being ruled out late in a 124-104 loss. Dallas is already thin in the frontcourt, so any missed time would tighten the rotation. Marvin Bagley III logged 20 minutes and has produced 16 points and 12 rebounds in one of his last three games, giving him short-term streaming appeal. P.J. Washington could also absorb more small-ball center minutes if needed.

Portland Trail Blazers center Robert Williams III (knee) has been downgraded to out for Thursday's game against the Jazz. Williams logged five points, five rebounds, and two blocks in 12 minutes Wednesday and remains on a light workload when active. His absence solidifies Donovan Clingan's role as the primary center and could open a few backup minutes for Yang Hansen. Hansen has totaled six points and five rebounds across his last five appearances, limiting him to emergency depth in deep leagues.

Portland Trail Blazers forward Deni Avdija (back) has been downgraded to out for Thursday's game against the Jazz. Avdija logged 11 points, five rebounds, and three assists in 27 minutes Wednesday but struggled to 21 percent shooting on 14 attempts. His absence opens usage on the wing, with Vit Krejci a clear beneficiary after posting 17 points on 7-of-10 shooting in 20 minutes. Sidy Cissoko could also see an expanded run. Jrue Holiday and Jerami Grant should shoulder more offensive responsibility, while Avdija remains a hold if this proves short-term.